AGEN
Agenus Inc
NASDAQ: AGEN · HEALTHCARE · BIOTECHNOLOGY
$3.26
-4.86% today
Updated 2026-06-05
Market cap
$144.92M
P/E ratio
1.70
P/S ratio
1.17x
EPS (TTM)
$2.05
Dividend yield
—
52W range
$3 – $7
Volume
0.9M
Agenus Inc (AGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.26
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.1B | $0.2B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 1.70x (capped 25x) · Margin: 52.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.